From 1 February 2021 pre-COVID-19 Special Authority criteria will be reinstated

PHARMAC

12 January 2020 - The temporary changes will remain in place for any Special Authority applications for the relevant medicines made up to 31 January 2021.

Last year, PHARMAC amended or removed funding criteria for many medicines in order to improve access to these treatments in anticipation of, and/or in response to, COVID-19 impacts on the health sector following the shift to Alert Level 4 in March 2020.

Read PHARMAC press release

Michael Wonder

Posted by:

Michael Wonder